Adherence to Monitoring Guidelines of Amiodarone Adverse Reactions

Area of Science:

• Cardiology
• Pharmacology
• Clinical Medicine

Background:

• Amiodarone treatment is associated with frequent adverse reactions.
• Clinical guidelines recommend comprehensive pre-treatment assessment and ongoing monitoring for amiodarone adverse effects.
• Evaluating adherence to these guidelines is crucial for patient safety.

Purpose of the Study:

• To assess the adherence to clinical guidelines for monitoring amiodarone adverse reactions.
• To identify areas of non-compliance in patient monitoring protocols.

Main Methods:

• Retrospective review of electronic medical records for adult patients on oral amiodarone for at least 12 months.
• Analysis of pre-treatment evaluations and periodic monitoring for various organ systems.
• Evaluation included thyroid, liver, cardiac, respiratory, ophthalmic, neurological, and dermatological assessments.

Main Results:

• High pre-treatment evaluation for liver (97%) and thyroid (97%) function, but inconsistent monitoring (liver 96% every 6 months, thyroid 59%).
• Chest X-ray was common pre-treatment (84%), but respiratory function tests were rare (2%); annual chest X-rays were not performed.
• Ophthalmologist visits were inconsistent (64% pre-treatment); neurological and dermatological evaluations were only done if symptoms arose. Annual cardiac reassessment adherence was 50%.

Conclusions:

• Adherence to clinical guidelines for monitoring amiodarone-induced adverse reactions is suboptimal.
• Significant deficiencies exist in the consistent monitoring of thyroid function, respiratory system, and ophthalmic health.
• There is a clear need for interventions to enhance compliance with established monitoring protocols to mitigate amiodarone risks.